Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys: 518 trades; $845.4M in total
Open-market sales: 1,246 trades; $1.4B in total
Insiders filing: 582 insiders; Last 7 days
Companies with several buyers: 35; Last 7 days

Vivos Therapeutics VVOS

		Trade type
10% Owner	Vivos TherapeuticsVVOS	Open-market buy	03/31	04/02	1,353,625 sh2 trades	$1.34avg.	$1,813,857.5	No record
CEO	Vivos TherapeuticsVVOS	Open-market buy	23/06/15–23/06/20	23/06/20	29,021 sh4 trades	$0.53avg.	$15,480.5	+50.5%
Ronald Kirk HuntsmanCEO	Vivos TherapeuticsVVOS	Open-market buy	23/06/14	23/06/15	10,000 sh	$0.49	$4,900	+21.1%